FDA Expands Presence outside U.S. with Opening of Mexico City Post

Mexico City | December 15, 2009

As part of its continuing effort to buttress food and medical product safety in the United States by working with its regulatory partners overseas, the U.S. Food and Drug Administration today announced the opening of a new office in Mexico City. This is the Agency’s third overseas office in Latin America and its tenth international office in the past 13 months.

“The opening of this office represents an important step as we re-design our product safety strategy. We, like our partners in the Mexican Government, realize that prevention is the key. For example, more than a third of the fresh fruits and vegetables sold and consumed in the United States come from Mexico, as do a large amount of medical devices. Having FDA experts located permanently in Mexico will be mutually beneficial to both our countries and respective citizens,” said U.S. FDA Commissioner Margaret A. Hamburg, M.D.

Staff assigned to the FDA’s Mexico City office will work with their Mexican counterparts to understand better our national regulations and guidance standards and to work on other collaborative initiatives. These collaborations will include information-sharing on the respective regulatory systems and joint workshops on the safety of food and medical products. Agencies in both governments also will make efforts to find opportunities for joint training on food-borne illnesses and the oversight of food traded internationally.

FDA staff in Mexico also will collaborate with Mexican counterparts on the use of the latest laboratory techniques, foster other collaborative initiatives to ensure the safety of food and medical products marketed in the two countries, and be a “portal” to the FDA for counterpart Mexican agencies and the US-export industry in Mexico.

“FDA staff will work with industry in Mexico as well,” said Murray M. Lumpkin, M.D., U.S. FDA Deputy Commissioner for International Programs. “FDA experts in Mexico City will work closely with local industries that ship food and medical products to the United States to improve their understanding of U.S. safety and product quality expectations. Their activities will include providing technical advice and working with government agencies and the private sector to develop certification programs.”

To date, the FDA has opened 10 international posts, including posts in China, India, Europe, and Latin America, along with its USA-based staff. The other posts in the Latin America Office are located in Santiago, Chile, and at the FDA’s Latin America Office headquarters in San José, Costa Rica.

For more information
HHS Web Page on Import Safety: http://www.importsafety.gov
FDA Web Page on International Programs
http://www.fda.gov/InternationalPrograms/default.htm